BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -17.93 Million USD | 29.21% |
| 2022 | -25.33 Million USD | -57.22% |
| 2021 | -16.11 Million USD | 13.06% |
| 2020 | -18.53 Million USD | -18.66% |
| 2019 | -15.62 Million USD | 25.2% |
| 2018 | -20.88 Million USD | -15.78% |
| 2017 | -18.03 Million USD | -20.56% |
| 2016 | -14.96 Million USD | 24.87% |
| 2015 | -19.91 Million USD | -11.0% |
| 2014 | -17.94 Million USD | -63.16% |
| 2013 | -10.99 Million USD | -334.45% |
| 2012 | -2.53 Million USD | 36.79% |
| 2011 | -4 Million USD | 65.17% |
| 2010 | -11.49 Million USD | -288.34% |
| 2009 | -2.96 Million USD | 66.3% |
| 2008 | -8.78 Million USD | 2.08% |
| 2007 | -8.97 Million USD | -85.41% |
| 2006 | -4.83 Million USD | 71.51% |
| 2005 | -16.98 Million USD | -81.41% |
| 2004 | -9.36 Million USD | -225.79% |
| 2003 | 7.44 Million USD | 199.92% |
| 2002 | 2.48 Million USD | 781.59% |
| 2001 | -364 Thousand USD | 89.98% |
| 2000 | -3.63 Million USD | 23.48% |
| 1999 | -4.74 Million USD | 6.9% |
| 1998 | -5.1 Million USD | -75.86% |
| 1997 | -2.9 Million USD | -16.0% |
| 1996 | -2.5 Million USD | -31.58% |
| 1995 | -1.9 Million USD | 51.28% |
| 1994 | -3.9 Million USD | 48.0% |
| 1993 | -7.5 Million USD | -36.36% |
| 1992 | -5.5 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.52 Million USD | 10.84% |
| 2024 Q2 | -3.22 Million USD | 28.86% |
| 2023 Q3 | -3.69 Million USD | 4.52% |
| 2023 Q1 | -5.29 Million USD | 37.21% |
| 2023 Q4 | -5.07 Million USD | -37.3% |
| 2023 FY | -17.93 Million USD | 29.21% |
| 2023 Q2 | -3.87 Million USD | 26.82% |
| 2022 Q2 | -5.05 Million USD | -20.19% |
| 2022 Q4 | -8.42 Million USD | -10.14% |
| 2022 FY | -25.33 Million USD | -57.22% |
| 2022 Q3 | -7.65 Million USD | -51.36% |
| 2022 Q1 | -4.2 Million USD | 5.03% |
| 2021 Q3 | -2.65 Million USD | 19.07% |
| 2021 Q4 | -4.42 Million USD | -66.69% |
| 2021 FY | -16.11 Million USD | 13.06% |
| 2021 Q1 | -6.06 Million USD | -9.44% |
| 2021 Q2 | -3.28 Million USD | 45.84% |
| 2020 Q3 | -3.66 Million USD | 7.84% |
| 2020 Q2 | -3.97 Million USD | 25.65% |
| 2020 Q1 | -5.35 Million USD | -75.59% |
| 2020 FY | -18.53 Million USD | -18.66% |
| 2020 Q4 | -5.53 Million USD | -51.05% |
| 2019 Q4 | -3.04 Million USD | 37.57% |
| 2019 FY | -15.62 Million USD | 25.2% |
| 2019 Q2 | -3.33 Million USD | 23.53% |
| 2019 Q1 | -4.36 Million USD | 32.99% |
| 2019 Q3 | -4.88 Million USD | -46.3% |
| 2018 Q1 | -5.18 Million USD | -9.81% |
| 2018 FY | -20.88 Million USD | -15.78% |
| 2018 Q4 | -6.51 Million USD | -44.39% |
| 2018 Q3 | -4.51 Million USD | 3.61% |
| 2018 Q2 | -4.67 Million USD | 9.74% |
| 2017 Q1 | -4.07 Million USD | 0.92% |
| 2017 Q3 | -4.76 Million USD | -6.27% |
| 2017 Q4 | -4.72 Million USD | 0.84% |
| 2017 FY | -18.03 Million USD | -20.56% |
| 2017 Q2 | -4.48 Million USD | -9.91% |
| 2016 FY | -14.96 Million USD | 24.87% |
| 2016 Q4 | -4.11 Million USD | -30.69% |
| 2016 Q3 | -3.14 Million USD | 7.06% |
| 2016 Q2 | -3.38 Million USD | 21.47% |
| 2016 Q1 | -4.31 Million USD | -89.58% |
| 2015 Q3 | -5.35 Million USD | 23.86% |
| 2015 Q4 | -2.27 Million USD | 57.49% |
| 2015 FY | -19.91 Million USD | -11.0% |
| 2015 Q2 | -7.02 Million USD | -33.66% |
| 2015 Q1 | -5.25 Million USD | -37.71% |
| 2014 FY | -17.94 Million USD | -63.16% |
| 2014 Q2 | -6.19 Million USD | -33.59% |
| 2014 Q3 | -3.29 Million USD | 46.79% |
| 2014 Q4 | -3.81 Million USD | -15.9% |
| 2014 Q1 | -4.63 Million USD | -128.78% |
| 2013 Q4 | -2.02 Million USD | 47.53% |
| 2013 Q3 | -3.86 Million USD | -68.46% |
| 2013 Q2 | -2.29 Million USD | 18.64% |
| 2013 Q1 | -2.81 Million USD | -336.33% |
| 2013 FY | -10.99 Million USD | -334.45% |
| 2012 FY | -2.53 Million USD | 36.79% |
| 2012 Q4 | 1.19 Million USD | 407.22% |
| 2012 Q3 | -388 Thousand USD | 77.35% |
| 2012 Q2 | -1.71 Million USD | -5.61% |
| 2012 Q1 | -1.62 Million USD | 16.52% |
| 2011 Q1 | -406 Thousand USD | -213.09% |
| 2011 Q2 | -717 Thousand USD | -76.6% |
| 2011 Q3 | -938 Thousand USD | -30.82% |
| 2011 Q4 | -1.94 Million USD | -107.14% |
| 2011 FY | -4 Million USD | 65.17% |
| 2010 Q3 | -2.42 Million USD | 41.19% |
| 2010 Q4 | 359 Thousand USD | 114.81% |
| 2010 Q1 | -5.3 Million USD | -276.72% |
| 2010 FY | -11.49 Million USD | -288.34% |
| 2010 Q2 | -4.12 Million USD | 22.34% |
| 2009 Q4 | -1.4 Million USD | -255.86% |
| 2009 Q2 | 2.47 Million USD | 150.19% |
| 2009 FY | -2.96 Million USD | 66.3% |
| 2009 Q3 | 904 Thousand USD | -63.46% |
| 2009 Q1 | -4.92 Million USD | -2.39% |
| 2008 Q2 | 386 Thousand USD | 168.81% |
| 2008 Q1 | -561 Thousand USD | 78.55% |
| 2008 Q3 | -3.79 Million USD | -1082.9% |
| 2008 FY | -8.78 Million USD | 2.08% |
| 2008 Q4 | -4.81 Million USD | -26.88% |
| 2007 Q3 | -3.58 Million USD | -288.84% |
| 2007 FY | -8.97 Million USD | -85.41% |
| 2007 Q2 | -923 Thousand USD | 49.92% |
| 2007 Q1 | -1.84 Million USD | -293.39% |
| 2007 Q4 | -2.61 Million USD | 27.14% |
| 2006 Q1 | -2.21 Million USD | -122.57% |
| 2006 FY | -4.83 Million USD | 71.51% |
| 2006 Q3 | -1.13 Million USD | 53.49% |
| 2006 Q4 | 953 Thousand USD | 184.04% |
| 2006 Q2 | -2.43 Million USD | -9.87% |
| 2005 FY | -16.98 Million USD | -81.41% |
| 2005 Q4 | -997 Thousand USD | 80.78% |
| 2005 Q3 | -5.18 Million USD | 20.61% |
| 2005 Q2 | -6.53 Million USD | -53.15% |
| 2005 Q1 | -4.26 Million USD | 53.6% |
| 2004 FY | -9.36 Million USD | -225.79% |
| 2004 Q3 | -2.3 Million USD | -338.76% |
| 2004 Q1 | 1.17 Million USD | -58.45% |
| 2004 Q2 | 965 Thousand USD | -17.52% |
| 2004 Q4 | -9.19 Million USD | -298.91% |
| 2003 FY | 7.44 Million USD | 199.92% |
| 2003 Q2 | 1.19 Million USD | 97.85% |
| 2003 Q1 | 604 Thousand USD | -39.42% |
| 2003 Q3 | 2.54 Million USD | 112.89% |
| 2003 Q4 | 2.81 Million USD | 10.69% |
| 2002 Q2 | 564 Thousand USD | 324.06% |
| 2002 Q4 | 997 Thousand USD | 26.36% |
| 2002 Q1 | 133 Thousand USD | -64.81% |
| 2002 Q3 | 789 Thousand USD | 39.89% |
| 2002 FY | 2.48 Million USD | 781.59% |
| 2001 FY | -364 Thousand USD | 89.98% |
| 2001 Q3 | 82 Thousand USD | 167.51% |
| 2001 Q1 | -761.33 Thousand USD | -30.0% |
| 2001 Q2 | -121.46 Thousand USD | 84.05% |
| 2001 Q4 | 378 Thousand USD | 360.98% |
| 2000 Q1 | -1.01 Million USD | 50.39% |
| 2000 Q4 | -585.62 Thousand USD | 49.01% |
| 2000 FY | -3.63 Million USD | 23.48% |
| 2000 Q3 | -1.14 Million USD | -30.02% |
| 2000 Q2 | -883.3 Thousand USD | 13.07% |
| 1999 FY | -4.74 Million USD | 6.9% |
| 1999 Q1 | -700 Thousand USD | 56.25% |
| 1999 Q2 | -1.2 Million USD | -71.43% |
| 1999 Q3 | -800 Thousand USD | 33.33% |
| 1999 Q4 | -2.04 Million USD | -156.02% |
| 1998 Q1 | -800 Thousand USD | 0.0% |
| 1998 FY | -5.1 Million USD | -75.86% |
| 1998 Q2 | -1.2 Million USD | -50.0% |
| 1998 Q3 | -1.5 Million USD | -25.0% |
| 1998 Q4 | -1.6 Million USD | -6.67% |
| 1997 Q1 | -800 Thousand USD | 0.0% |
| 1997 FY | -2.9 Million USD | -16.0% |
| 1997 Q4 | -800 Thousand USD | -60.0% |
| 1997 Q3 | -500 Thousand USD | 44.44% |
| 1997 Q2 | -900 Thousand USD | -12.5% |
| 1996 Q2 | -500 Thousand USD | 0.0% |
| 1996 Q1 | -500 Thousand USD | -25.0% |
| 1996 FY | -2.5 Million USD | -31.58% |
| 1996 Q4 | -800 Thousand USD | -33.33% |
| 1996 Q3 | -600 Thousand USD | -20.0% |
| 1995 Q4 | -400 Thousand USD | -100.0% |
| 1995 Q2 | -400 Thousand USD | 50.0% |
| 1995 Q1 | -800 Thousand USD | 46.67% |
| 1995 Q3 | -200 Thousand USD | 50.0% |
| 1995 FY | -1.9 Million USD | 51.28% |
| 1994 Q2 | -500 Thousand USD | -350.0% |
| 1994 Q4 | -1.5 Million USD | -66.67% |
| 1994 Q3 | -900 Thousand USD | -80.0% |
| 1994 Q1 | 200 Thousand USD | 108.0% |
| 1994 FY | -3.9 Million USD | 48.0% |
| 1993 Q4 | -2.5 Million USD | -56.25% |
| 1993 FY | -7.5 Million USD | -36.36% |
| 1993 Q3 | -1.6 Million USD | 15.79% |
| 1993 Q2 | -1.9 Million USD | -26.67% |
| 1993 Q1 | -1.5 Million USD | 37.5% |
| 1992 FY | -5.5 Million USD | 0.0% |
| 1992 Q4 | -2.4 Million USD | -140.0% |
| 1992 Q2 | -1.2 Million USD | -185.71% |
| 1992 Q3 | -1 Million USD | 16.67% |
| 1992 Q1 | 1.4 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -24.901% |
| Cerus Corporation | -30.05 Million USD | 40.315% |
| OrthoPediatrics Corp. | -25.76 Million USD | 30.385% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -68.877% |
| Talis Biomedical Corporation | -66.81 Million USD | 73.154% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -3.706% |
| Inogen, Inc. | -109.38 Million USD | 83.602% |
| Spectral AI, Inc. | -12.98 Million USD | -38.147% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 71.342% |
| CVRx, Inc. | -43.1 Million USD | 58.386% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -408.418% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -44.327% |
| Orthofix Medical Inc. | -139.11 Million USD | 87.106% |
| Venus Concept Inc. | -28.3 Million USD | 36.639% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 66.801% |
| Bioventus Inc. | -81.72 Million USD | 78.052% |
| BrainsWay Ltd. | -4.92 Million USD | -264.055% |
| Envoy Medical, Inc. | -18.37 Million USD | 2.362% |
| electroCore, Inc. | -18.8 Million USD | 4.616% |
| IceCure Medical Ltd | -15.57 Million USD | -15.158% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 63.003% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -3.874% |
| MaxCyte, Inc. | -48.29 Million USD | 62.863% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -50.035% |
| Nexalin Technology, Inc. | -5.69 Million USD | -214.889% |
| PAVmed Inc | -68.79 Million USD | 73.927% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 68.288% |
| RxSight, Inc. | -50.08 Million USD | 64.187% |
| Sight Sciences, Inc. | -57.27 Million USD | 68.682% |
| SI-BONE, Inc. | -46.93 Million USD | 61.78% |
| TELA Bio, Inc. | -44.07 Million USD | 59.303% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 66.875% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 65.122% |
| LivaNova PLC | -68.49 Million USD | 73.814% |
| 908 Devices Inc. | -42.75 Million USD | 58.05% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 89.655% |
| Nemaura Medical Inc. | -9.59 Million USD | -86.937% |
| NeuroPace, Inc. | -27.17 Million USD | 33.992% |
| LENSAR, Inc. | -12.22 Million USD | -46.676% |
| Apyx Medical Corporation | -17.25 Million USD | -3.928% |
| Cutera, Inc. | -156.23 Million USD | 88.519% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -108.473% |
| BioSig Technologies, Inc. | -28.51 Million USD | 37.09% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 79.533% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 20.088% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 116.083% |
| Axonics, Inc. | -26.05 Million USD | 31.162% |
| Outset Medical, Inc. | -169.77 Million USD | 89.435% |
| IRIDEX Corporation | -10 Million USD | -79.245% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 83.57% |
| IRadimed Corporation | 20.03 Million USD | 189.526% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -117.55% |
| INVO Bioscience, Inc. | -6.76 Million USD | -165.06% |
| Telesis Bio, Inc. | -35.15 Million USD | 48.97% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 225.171% |
| Varex Imaging Corporation | 32.1 Million USD | 155.879% |
| Quipt Home Medical Corp. | 3.91 Million USD | 557.693% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -47.836% |
| Pulmonx Corporation | -61.93 Million USD | 71.039% |
| Dynatronics Corporation | -2.27 Million USD | -689.117% |
| Modular Medical, Inc. | -17.52 Million USD | -2.328% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -22.529% |
| Semler Scientific, Inc. | 22.25 Million USD | 180.594% |
| InMode Ltd. | 195.66 Million USD | 109.167% |
| Bruker Corporation | 436.9 Million USD | 104.106% |
| Cytosorbents Corporation | -31.2 Million USD | 42.527% |
| DexCom, Inc. | 597.7 Million USD | 103.001% |
| Align Technology, Inc. | 643.33 Million USD | 102.788% |
| Viveve Medical, Inc. | -21.55 Million USD | 16.777% |
| ZimVie Inc. | -30.93 Million USD | 42.025% |
| Movano Inc. | -29.69 Million USD | 39.586% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 35.583% |
| Nexalin Technology, Inc. | -5.69 Million USD | -214.889% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -408.418% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 92.309% |
| Profound Medical Corp. | -28.61 Million USD | 37.318% |
| Insulet Corporation | 220 Million USD | 108.153% |
| enVVeno Medical Corporation | -25.23 Million USD | 28.929% |
| Surmodics, Inc. | -5.64 Million USD | -217.75% |
| iCAD, Inc. | -7.68 Million USD | -133.281% |
| Nuwellis, Inc. | -17.63 Million USD | -1.741% |
| Biotricity, Inc. | -8.82 Million USD | -103.177% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 85.669% |
| Aethlon Medical, Inc. | -12.63 Million USD | -41.945% |
| InspireMD, Inc. | -21.14 Million USD | 15.163% |
| PAVmed Inc. | -68.79 Million USD | 73.927% |
| Beyond Air, Inc. | -63 Million USD | 71.531% |
| FONAR Corporation | 16.53 Million USD | 208.477% |
| AxoGen, Inc. | -21.46 Million USD | 16.424% |
| Vivani Medical, Inc. | -26.96 Million USD | 33.48% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 199.424% |
| Inari Medical, Inc. | -14.03 Million USD | -27.829% |
| UFP Technologies, Inc. | 57.66 Million USD | 131.106% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -264.011% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -184.454% |
| Tenon Medical, Inc. | -15.72 Million USD | -14.052% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -139.992% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 57.999% |
| AdaptHealth Corp. | -598.4 Million USD | 97.003% |
| Sintx Technologies, Inc. | -13.35 Million USD | -34.279% |
| NanoVibronix, Inc. | -3.43 Million USD | -422.031% |
| Quanterix Corporation | -49.7 Million USD | 63.91% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -47.836% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -4595.55% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 94.637% |
| TransMedics Group, Inc. | -28.72 Million USD | 37.56% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 24.034% |
| NeuroMetrix, Inc. | -7.15 Million USD | -150.814% |
| Hyperfine, Inc. | -48.11 Million USD | 62.721% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 72.416% |
| Biomerica, Inc. | -6.36 Million USD | -181.718% |
| Bone Biologics Corporation | -9.42 Million USD | -90.246% |
| AVITA Medical, Inc. | -40.4 Million USD | 55.604% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -73.956% |
| Silk Road Medical, Inc | -59.27 Million USD | 69.737% |